hipages Group Holdings Limited announced the appointment of Ms. Kate Hill as an Independent Non-Executive Director with effect from 25 August 2023. Kate is an accountant and public company director with over 30 years' experience working with listed and private companies, including over 20 years as an audit partner with Deloitte in Australia. She has extensive audit and capital markets experience, including Initial Public Offerings, capital raising, governance and compliance.

She held a variety of leadership and executive roles within Deloitte, including serving for a period on the Board of Partners of the Australian firm. Kate is an Independent Non-Executive Director of Count Limited, where she is also Chair of the Audit and Risk Committee and a member of the Acquisitions Committee. She is also an Independent Non-Executive Director of Artrya Limited and of MedAdviser Limited, where she is the Chair of the Audit and Risk Committee and a member of the Remuneration and Nominations Committee, as well as Chair of UK-listed Seeing Machines Limited, where she is a member of the Finance and Risk Committee, and the People and Culture Committee.

Kate holds a Bachelor of Science (Hons) from Bristol University, is a member of the Institute of Chartered Accountants in Australia and New Zealand, and a graduate of the Australian Institute of Company Directors. Kate will become Chair of the hipages Group Audit and Risk Committee, succeeding Stacey Brown who retires from the Board in August to take up an executive role as Chief Financial Officer of the Foxtel Group (NXE Australia Pty Ltd).